Determination of organ doses and effective doses in radiooncology;Bestimmung von organdosen und effektiven dosen in der radioonkologie

Strahlentherapie und Onkologie

Volumn 183, Issue 7, 2007, Pages 392-397

  Roth, Jakob ^a   Martinez, Aurélien Emmanuel ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Effective dose; Megavoltage therapy; Organ doses; Radiation risk

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; COMPUTER PROGRAM; ORGAN; RADIATION DOSE; RADIOSENSITIVITY;

BODY BURDEN; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; ORGAN SPECIFICITY; RADIATION ONCOLOGY; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RELATIVE BIOLOGICAL EFFECTIVENESS; SOFTWARE;

EID: 34447128950     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1697-y     Document Type: Article

References (15)

1. Akmansu M, Dirican B, Bora H, et al. The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves' orbitopathy. Ophthalmic Res 2003;36:150-3.
2. Aroua A, Moeckli R, Valley JF, et al. Enquête sur la pratique da la radiothérapie en Suisse en 2003. Rapport. Lausanne: Institut Universitaire de Radiophysique Appliquée, 2006.
3. Bölling T, Schuck A, Hesselmann S, et al. Behandlungsassoziierte Spätfolgen nach Strahlentherapie maligner Erkrankungen im Kindes- und Jugendalter. Strahlenther Onkol 2006;182:443-9.
4. Diallo I, Lamon A, Shamsaldin A, et al. Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol 1996;38:269-71.
5. Dörr W, Bertmann S, Herrmann T. Radiation-induced lung reactions in breast cancer therapy. Strahlenther Onkol 2005;181:567-73.
6. Dörr W, Herrmann T. Second primary tumors after radiotherapy for malignancies. Strahlenther Onkol 2002;178:357-62.
7. International Commission on Radiological Protection. 1990 recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Oxford: Pergamon Press, 1991.
8. National Radiological Protection Board. Risks of second cancer in therapeutically irradiated populations. Report of an advisory group on ionising radiation. Doc NRPB 2000;11:11-5.
9. Roth J, Roser HW, Schnekenburger B. Gedanken zur effektiven Dosis in der Radio-Onkologie. In: Welker K, Zink K, Hrsg. Medizinische Physik 2001. Berlin: DGMP, 2001:307-8.
10. Schneider U, Lomax A, Pemler P, et al. The impact of IMRT and proton radiotherapy on secondary cancer incidence. Strahlenther Onkol 2006;182:647-52.
11. Trott KR, Kamprad F. Estimation of cancer risks from radiotherapy of benign diseases. Strahlenther Onkol 2006;182:431-6.
12. UNSCEAR 1993 Report. Sources and effects of ionizing radiation. New York: United Nations, 1993.
13. UNSCEAR 2000 Report. Sources and effects of ionizing radiation, vol I: Sources, Annex D. New York: United Nations, 2002.
14. Van der Giessen PH. Peridose, a software program to calculate the dose outside the primary beam in radiation therapy. Radiother Oncol 2001;58:209-13.
15. Williams G, Zankl M, Drexler G. The calculation of dose from external photon exposures using reference human phantoms and Monte Carlo methods. Part IV: Organ doses in radiotherapy. GSF-Bericht S-1054. München: GSF, 1987.